CY1403A - Benzazepin-2-ones - Google Patents

Benzazepin-2-ones

Info

Publication number
CY1403A
CY1403A CY140382A CY140382A CY1403A CY 1403 A CY1403 A CY 1403A CY 140382 A CY140382 A CY 140382A CY 140382 A CY140382 A CY 140382A CY 1403 A CY1403 A CY 1403A
Authority
CY
Cyprus
Prior art keywords
benzazepin
ones
Prior art date
Application number
CY140382A
Other languages
English (en)
Inventor
William Herbert Watthe Jeffrey
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of CY1403A publication Critical patent/CY1403A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06086Dipeptides with the first amino acid being basic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
CY140382A 1981-08-11 1982-08-05 Benzazepin-2-ones CY1403A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29190781A 1981-08-11 1981-08-11
US31986381A 1981-11-09 1981-11-09

Publications (1)

Publication Number Publication Date
CY1403A true CY1403A (en) 1987-12-18

Family

ID=26967047

Family Applications (1)

Application Number Title Priority Date Filing Date
CY140382A CY1403A (en) 1981-08-11 1982-08-05 Benzazepin-2-ones

Country Status (22)

Country Link
EP (1) EP0072352B1 (fi)
KR (3) KR890003425B1 (fi)
AR (3) AR240806A1 (fi)
AT (1) ATE18397T1 (fi)
AU (1) AU561395B2 (fi)
CA (1) CA1196636A (fi)
CY (1) CY1403A (fi)
DD (1) DD202546A5 (fi)
DE (1) DE3269625D1 (fi)
DK (1) DK157881C (fi)
ES (6) ES514856A0 (fi)
FI (1) FI76074C (fi)
GB (1) GB2103614B (fi)
GR (1) GR77256B (fi)
HK (1) HK93387A (fi)
HU (1) HU189628B (fi)
IE (1) IE53668B1 (fi)
IL (1) IL66501A (fi)
NL (1) NL930112I2 (fi)
NO (1) NO161558C (fi)
NZ (1) NZ201555A (fi)
PT (1) PT75395B (fi)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3242599A1 (de) * 1982-11-18 1984-05-24 Dr. Karl Thomae Gmbh, 7950 Biberach Neue benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel
US4473575A (en) * 1982-07-19 1984-09-25 Ciba-Geigy Corporation 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
DE3373469D1 (en) * 1982-09-30 1987-10-15 Merck & Co Inc 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents
US4575503A (en) * 1983-02-10 1986-03-11 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4564612A (en) * 1983-04-22 1986-01-14 Takeda Chemical Industries, Ltd. Condensed, seven-membered ring compounds and their use
JPS608284A (ja) * 1983-06-29 1985-01-17 Mitsui Toatsu Chem Inc ベンゾチアゼピン誘導体およびその製造法
US4539150A (en) * 1983-06-29 1985-09-03 Mitsui Toatsu Chemicals, Inc. Benzothiazepine derivatives and their methods of preparation
AU570710B2 (en) * 1983-08-12 1988-03-24 Takeda Chemical Industries Ltd. 4-oxo-2, 3, 4, 5-tetrahydro-1, 5-benzoxazepine derivatives
US4638000A (en) * 1983-08-12 1987-01-20 Takeda Chemical Industries, Ltd. Condensed seven-membered ring compounds, their production and use
IL72523A (en) * 1983-08-12 1988-06-30 Takeda Chemical Industries Ltd 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives,their production and pharmaceutical compositions containing them
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
EP0166354B1 (en) * 1984-06-26 1992-08-05 Merck & Co. Inc. Benzofused lactam compounds and pharmaceutical compositions containing them
CA1266647A (en) * 1984-06-26 1990-03-13 William H. Parsons Benzofused lactams useful as antihypertensive agents and as cholecystokinin antagonists
US4785089A (en) * 1985-06-13 1988-11-15 Ciba-Geigy Corporation Novel sulfonic acid esters and their preparation
DE3704661A1 (de) * 1987-02-14 1988-08-25 Hoechst Ag Annelierte azepinon- und azocinon-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung, sowie zwischenprodukte bei ihrer herstellung
EP0322779A3 (en) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolactam compounds and pharmaceutical uses thereof
TW197945B (fi) * 1990-11-27 1993-01-11 Hoechst Ag
GB9100028D0 (en) * 1991-01-02 1991-02-20 Ici Plc Compounds
GB9212308D0 (en) * 1992-06-10 1992-07-22 Ici Plc Therapeutic compositions
US5504080A (en) * 1992-10-28 1996-04-02 Bristol-Myers Squibb Co. Benzo-fused lactams
US5610153A (en) * 1992-12-11 1997-03-11 Ciba-Geigy Corporation Benzazepinone derivatives
GB9310075D0 (en) * 1993-05-17 1993-06-30 Fujisawa Pharmaceutical Co New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
US5801168A (en) * 1994-06-09 1998-09-01 Zeneca Limited Substituted nitrogen heterocycles
US5597922A (en) * 1994-07-29 1997-01-28 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Glycine receptor antagonist pharmacophore
MXPA02005070A (es) * 1999-11-18 2003-09-25 Antexpharma Inc 1-benzazepinas sustituidas y derivados de las mismas.
EP2256104A1 (en) 2000-12-27 2010-12-01 Merck Patent GmbH Process for the preparation of alpha-aminosubstituted carboxylic acid amides
CN1585744A (zh) 2001-03-27 2005-02-23 兰贝克赛实验室有限公司 贝那普利的制备方法
EP1443919A4 (en) 2001-11-16 2006-03-22 Bristol Myers Squibb Co DOUBLE INHIBITORS OF THE FATTY ACID BINDING PROTEIN OF THE ADIPOCYTES AND THE FATTY ACID BINDING PROTEIN OF KERATINOCYTES
EP1525189A1 (en) * 2002-07-26 2005-04-27 Ciba Specialty Chemicals Holding Inc. Crystalline polymorphic and amorphous forms of benazepril hydrochloride
KR100710548B1 (ko) * 2002-12-26 2007-04-24 에스케이 주식회사 (s)-3-아미노-2,3,4,5-테트라히드로-2-옥소-1H-1-벤자제핀-1-아세트산 및 이의 에스테르 화합물의 제조방법
US7459474B2 (en) 2003-06-11 2008-12-02 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8080579B2 (en) 2005-10-03 2011-12-20 The Regents Of The University Of Michigan Compositions and methods for treatment of inflammatory bowel disease
US7592461B2 (en) 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
EP2089355A2 (en) 2006-11-01 2009-08-19 Brystol-Myers Squibb Company Modulators of glucocorticoid receptor, ap-1, and/or nf- kappa b activity and use thereof
JP2010508358A (ja) 2006-11-01 2010-03-18 ブリストル−マイヤーズ スクイブ カンパニー グルココルチコイド受容体、AP−1、および/またはNF−κB活性の調節剤、並びにその使用
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2170930B3 (en) 2007-06-04 2013-10-02 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US7828840B2 (en) 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
WO2009158380A1 (en) 2008-06-24 2009-12-30 Bristol-Myers Squibb Company Cyclopentathiophene modulators of the glucocorticoid receptor, ap-1, and/or nf-kappa b activity and use thereof
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP3004138B1 (en) 2013-06-05 2024-03-13 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
US9593113B2 (en) 2013-08-22 2017-03-14 Bristol-Myers Squibb Company Imide and acylurea derivatives as modulators of the glucocorticoid receptor
CN113292495B (zh) * 2021-06-18 2022-09-13 迪嘉药业集团有限公司 一种 (s)-氨基化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395150A (en) * 1965-02-26 1968-07-30 Squibb & Sons Inc Benzothiazepine carboxamides and derivatives thereof
GB1305278A (fi) * 1970-03-12 1973-01-31

Also Published As

Publication number Publication date
ES530658A0 (es) 1985-12-01
ES526886A0 (es) 1985-11-01
NL930112I1 (nl) 1993-10-18
FI822770A0 (fi) 1982-08-09
NZ201555A (en) 1986-06-11
PT75395B (en) 1985-11-15
HU189628B (en) 1986-07-28
ES526889A0 (es) 1986-02-01
DE3269625D1 (en) 1986-04-10
ES526888A0 (es) 1985-04-16
EP0072352A1 (de) 1983-02-16
AR241222A1 (es) 1992-02-28
GR77256B (fi) 1984-09-11
IL66501A0 (en) 1982-12-31
IE821929L (en) 1983-02-11
ES526887A0 (es) 1986-04-16
AU8701482A (en) 1983-05-12
FI76074B (fi) 1988-05-31
PT75395A (en) 1982-09-01
ES8502974A1 (es) 1985-02-01
FI76074C (fi) 1988-09-09
ES8504728A1 (es) 1985-04-16
ES514856A0 (es) 1985-02-01
KR900001191B1 (ko) 1990-02-28
AR240806A1 (es) 1991-02-28
NL930112I2 (nl) 1996-11-01
NO822722L (no) 1983-02-14
ES8606285A1 (es) 1986-04-16
GB2103614B (en) 1984-11-21
ES8601142A1 (es) 1985-11-01
NO161558B (no) 1989-05-22
AU561395B2 (en) 1987-05-07
KR840001139A (ko) 1984-03-28
DK358682A (da) 1983-02-12
CA1196636A (en) 1985-11-12
AR240807A1 (es) 1991-02-28
IE53668B1 (en) 1989-01-04
KR900001190B1 (ko) 1990-02-28
ES8604523A1 (es) 1986-02-01
DK157881C (da) 1990-07-23
DD202546A5 (de) 1983-09-21
ES8602682A1 (es) 1985-12-01
AR240807A2 (es) 1991-02-28
GB2103614A (en) 1983-02-23
AR240806A2 (es) 1991-02-28
HK93387A (en) 1987-12-18
KR890003425B1 (ko) 1989-09-20
ATE18397T1 (de) 1986-03-15
NO161558C (no) 1989-08-30
IL66501A (en) 1987-10-20
EP0072352B1 (de) 1986-03-05
DK157881B (da) 1990-02-26
FI822770L (fi) 1983-02-12

Similar Documents

Publication Publication Date Title
GB2103614B (en) Benzazepin-2-ones
CS144682A2 (en) Pletaci stroj
HK7289A (en) 2-arylimidazo-pyridines
GB2104365B (en) Cloches
GB2105449B (en) Graindryer
BG48180A1 (en) Stereocomparator
KE3594A (en) 2-nitroimidazoles
CS15282A1 (en) Zdroj srovnavaciho napeti
MW4482A1 (en) 2-nitroimidazoles
GB2101993B (en) Pyrimidoindoles
CA48859S (en) Hairslide
CA48729S (en) Infiltrometer
CA47741S (en) Walking-board
CA48858S (en) Bobbypin
ZA823347B (en) Skerm
AU83569S (en) key-blank
BG35558A1 (en) Devider- separator
CS460581A1 (en) Odkalovaci cirkulacni pracka
CS537781A1 (en) Slnecny kolektor
CS638882A1 (en) Zpusob kultivace metylotrofnich bakterii
CS814281A1 (en) Koncovy spinac polohy
AU83567S (en) key-blank
CS144581A1 (en) Vyztuha skolni aktovky
AU83568S (en) key-blank
CS14081A1 (en) Posilovac dverniho zamku